Drug Shortage Report for TEVA-CITALOPRAM

Last updated on 2022-02-17 History
Report ID 142622
Drug Identification Number 02293226
Brand name TEVA-CITALOPRAM
Common or Proper name CITALOPRAM 40MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CITALOPRAM
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 & P Pack 30
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-07-13
Estimated end date 2022-03-28
Actual end date 2022-02-16
Shortage status Resolved
Updated date 2022-02-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2022-02-17 French Compare
v20 2022-02-17 English Compare
v19 2022-02-04 French Compare
v18 2022-02-04 English Compare
v17 2021-12-17 French Compare
v16 2021-12-17 English Compare
v15 2021-11-18 French Compare
v14 2021-11-18 English Compare
v13 2021-11-04 French Compare
v12 2021-11-04 English Compare
v11 2021-10-21 French Compare
v10 2021-10-21 English Compare
v9 2021-09-23 French Compare
v8 2021-09-23 English Compare
v7 2021-09-09 French Compare
v6 2021-09-09 English Compare
v5 2021-08-27 French Compare
v4 2021-08-27 English Compare
v3 2021-08-27 English Compare
v2 2021-07-15 French Compare

Showing 1 to 20 of 21